Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Ovarian Neoplasms

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 45 articles:
HTML format
Text format



Single Articles


    September 2017
  1. GAITSKELL K, Green J, Pirie K, Barnes I, et al
    Histological subtypes of ovarian cancer associated with parity and breastfeeding in the prospective Million Women Study.
    Int J Cancer. 2017 Sep 20. doi: 10.1002/ijc.31063.
    PubMed     Text format     Abstract available


  2. RICE MS, Rist PM, Winter AC, Kurth T, et al
    Migraine and invasive epithelial ovarian cancer risk in the Nurses' Health Study II and the Women's Health Study.
    Int J Cancer. 2017 Sep 20. doi: 10.1002/ijc.31062.
    PubMed     Text format     Abstract available


  3. JUNG S, Allen N, Arslan AA, Baglietto L, et al
    Anti-Mullerian Hormone and risk of ovarian cancer in nine cohorts.
    Int J Cancer. 2017 Sep 18. doi: 10.1002/ijc.31058.
    PubMed     Text format     Abstract available


    August 2017
  4. BABIC A, Harris HR, Vitonis AF, Titus LJ, et al
    Menstrual pain and risk of epithelial ovarian cancer: results from the Ovarian Cancer Association Consortium.
    Int J Cancer. 2017 Aug 22. doi: 10.1002/ijc.31010.
    PubMed     Text format     Abstract available


  5. WU YH, Huang YF, Chang TH, Chou CY, et al
    Activation of TWIST1 by COL11A1 promotes chemoresistance and inhibits apoptosis in ovarian cancer cells by modulating NF-kappaB-mediated IKKbeta expression.
    Int J Cancer. 2017 Aug 17. doi: 10.1002/ijc.30932.
    PubMed     Text format     Abstract available


  6. MORCH LS, Dehlendorff C, Baandrup L, Friis S, et al
    Use of antidepressants and risk of epithelial ovarian cancer.
    Int J Cancer. 2017 Aug 9. doi: 10.1002/ijc.30919.
    PubMed     Text format     Abstract available


    July 2017
  7. WU AH, Pearce CL, Lee A, Tseng C, et al
    Timing of births and oral contraceptive use influences ovarian cancer risk.
    Int J Cancer. 2017 Jul 27. doi: 10.1002/ijc.30910.
    PubMed     Text format     Abstract available


  8. KRITSCH D, Hoffmann F, Steinbach D, Jansen L, et al
    Tribbles 2 mediates cisplatin sensitivity and DNA damage response in epithelial ovarian cancer.
    Int J Cancer. 2017 Jul 3. doi: 10.1002/ijc.30860.
    PubMed     Text format     Abstract available


    April 2017
  9. VERDOODT F, Kjaer Hansen M, Kjaer SK, Pottegard A, et al
    Statin use and mortality among ovarian cancer patients: A population-based cohort study.
    Int J Cancer. 2017 Apr 15. doi: 10.1002/ijc.30738.
    PubMed     Text format     Abstract available


    March 2017
  10. STALBERG K, Kjolhede P, Bjurberg M, Borgfeldt C, et al
    Risk factors for lymph node metastases in women with endometrial cancer: A population-based, nation-wide register study - On behalf of the Swedish gynecological cancer group (SweGCG).
    Int J Cancer. 2017 Mar 24. doi: 10.1002/ijc.30707.
    PubMed     Text format     Abstract available


  11. COBURN SB, Bray F, Sherman ME, Trabert B, et al
    International patterns and trends in ovarian cancer incidence, overall and by histologic subtype.
    Int J Cancer. 2017 Mar 3. doi: 10.1002/ijc.30676.
    PubMed     Text format     Abstract available


    February 2017
  12. SHI T, Wang P, Xie C, Yin S, et al
    BRCA1 and BRCA2 mutations in ovarian cancer patients from China: Ethnic-related mutations in BRCA1 associated with an increased risk of ovarian cancer.
    Int J Cancer. 2017 Feb 8. doi: 10.1002/ijc.30633.
    PubMed     Text format     Abstract available


    January 2017
  13. PRAESTEGAARD C, Jensen A, Jensen SM, Nielsen TS, et al
    Cigarette smoking is associated with adverse survival among women with ovarian cancer: results from a pooled analysis of 19 studies.
    Int J Cancer. 2017 Jan 7. doi: 10.1002/ijc.30600.
    PubMed     Text format     Abstract available


    December 2016
  14. TANG FH, Hsieh TH, Hsu CY, Lin HY, et al
    KRAS mutation coupled with p53 loss is sufficient to induce ovarian carcinosarcomas in mice.
    Int J Cancer. 2016 Dec 29. doi: 10.1002/ijc.30591.
    PubMed     Text format     Abstract available


  15. GARCIA-SANZ P, Trivino JC, Mota A, Perez Lopez M, et al
    Chromatin remodelling and DNA repair genes are frequently mutated in endometrioid endometrial carcinoma.
    Int J Cancer. 2016 Dec 20. doi: 10.1002/ijc.30573.
    PubMed     Text format     Abstract available


  16. JONES NL, Xiu J, Chatterjee-Paer S, Buckley de Meritens A, et al
    Distinct molecular landscapes between endometrioid and non-endometrioid uterine carcinomas.
    Int J Cancer. 2016 Dec 1. doi: 10.1002/ijc.30537.
    PubMed     Text format     Abstract available


    October 2016
  17. TRABERT B, Eldridge RC, Pfeiffer RM, Shiels MS, et al
    Pre-diagnostic circulating inflammation markers and endometrial cancer risk in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial.
    Int J Cancer. 2016 Oct 22. doi: 10.1002/ijc.30478.
    PubMed     Text format     Abstract available


  18. PERES LC, Bandera EV, Qin B, Guertin KA, et al
    Dietary Inflammatory Index and Risk of Epithelial Ovarian Cancer in African American Women.
    Int J Cancer. 2016 Oct 11. doi: 10.1002/ijc.30467.
    PubMed     Text format     Abstract available


    September 2016
  19. HARRIS HR, Titus LJ, Cramer DW, Terry KL, et al
    Long and irregular menstrual cycles, polycystic ovary syndrome, and ovarian cancer risk in a population-based case-control study.
    Int J Cancer. 2016 Sep 26. doi: 10.1002/ijc.30441.
    PubMed     Text format     Abstract available


  20. KRAUS C, Hoyer J, Vasileiou G, Wunderle M, et al
    Gene panel sequencing in familial Breast/Ovarian Cancer patients identifies multiple novel mutations also in genes others than BRCA1/2.
    Int J Cancer. 2016 Sep 12. doi: 10.1002/ijc.30428.
    PubMed     Text format     Abstract available


    August 2016
  21. VOLOSHIN T, Munster M, Blatt R, Shteingauz A, et al
    Alternating Electric Fields (TTFields) in Combination with Paclitaxel are Therapeutically Effective against Ovarian Cancer Cells in vitro and in vivo.
    Int J Cancer. 2016 Aug 25. doi: 10.1002/ijc.30406.
    PubMed     Text format     Abstract available


  22. MARSHALL AD, van Geldermalsen M, Otte NJ, Anderson L, et al
    LAT1 is a Putative Therapeutic Target in Endometrioid Endometrial Carcinoma.
    Int J Cancer. 2016 Aug 3. doi: 10.1002/ijc.30371.
    PubMed     Text format     Abstract available


    July 2016
  23. LEE AW, Bomkamp A, Bandera EV, Jensen A, et al
    A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer.
    Int J Cancer. 2016 Jul 15. doi: 10.1002/ijc.30274.
    PubMed     Text format     Abstract available


    June 2016
  24. ALSINA-SANCHIS E, Figueras A, Lahiguera A, Vidal A, et al
    The TGFbeta pathway stimulates ovarian cancer cell proliferation by increasing IGF1R levels.
    Int J Cancer. 2016 Jun 14. doi: 10.1002/ijc.30233.
    PubMed     Text format     Abstract available


    May 2016
  25. OREN R, Addadi Y, Narunsky Haziza L, Dafni H, et al
    Fibroblast recruitment as a tool for ovarian cancer detection and targeted therapy.
    Int J Cancer. 2016 May 31. doi: 10.1002/ijc.30209.
    PubMed     Text format     Abstract available


  26. KELLY Z, Moller-Levet C, McGrath S, Butler-Manuel S, et al
    The prognostic significance of specific HOX gene expression patterns in ovarian cancer.
    Int J Cancer. 2016 May 26. doi: 10.1002/ijc.30204.
    PubMed     Text format     Abstract available


    April 2016
  27. CIRILLO PM, Wang ET, Cedars MI, Chen LM, et al
    Irregular menses predicts ovarian cancer: Prospective evidence from the Child Health and Development Studies.
    Int J Cancer. 2016 Apr 15. doi: 10.1002/ijc.30144.
    PubMed     Text format     Abstract available


    March 2016
  28. BANDERA EV, Qin B, Moorman PG, Alberg AJ, et al
    Obesity, weight gain, and ovarian cancer risk in African American women.
    Int J Cancer. 2016 Mar 31. doi: 10.1002/ijc.30115.
    PubMed     Text format     Abstract available


  29. HUANG T, Poole EM, Eliassen AH, Okereke OI, et al
    Hypertension, use of antihypertensive medications, and risk of epithelial ovarian cancer.
    Int J Cancer. 2016 Mar 2. doi: 10.1002/ijc.30066.
    PubMed     Text format     Abstract available


    January 2016
  30. RUSSELL MR, Walker MJ, Williamson AJ, Gentry-Maharaj A, et al
    Protein Z: A putative novel biomarker for early detection of ovarian cancer.
    Int J Cancer. 2016 Jan 27. doi: 10.1002/ijc.30020.
    PubMed     Text format     Abstract available


  31. ALTMAN D, Yin L, Falconer H
    Long-term cancer risk after hysterectomy on benign indications: population-based cohort study.
    Int J Cancer. 2016 Jan 21. doi: 10.1002/ijc.30011.
    PubMed     Text format     Abstract available


    November 2015
  32. KUROSAKI A, Hasegawa K, Kato T, Abe K, et al
    Serum folate receptor alpha (FRA) as a biomarker for ovarian cancer: Implications for diagnosis, prognosis and predicting its local tumor expression.
    Int J Cancer. 2015 Nov 23. doi: 10.1002/ijc.29937.
    PubMed     Text format     Abstract available


    October 2015
  33. YANG X, Shen J, Gao Y, Feng Y, et al
    Nsc23925 prevents the development of paclitaxel resistance by inhibiting the introduction of P-glycoprotein and enhancing apoptosis.
    Int J Cancer. 2015;137:2029-39.
    PubMed     Text format     Abstract available


  34. QUARTUCCIO SM, Karthikeyan S, Eddie SL, Lantvit DD, et al
    Mutant p53 expression in fallopian tube epithelium drives cell migration.
    Int J Cancer. 2015;137:1528-38.
    PubMed     Text format     Abstract available


    September 2015
  35. GAITSKELL K, Green J, Pirie K, Reeves G, et al
    Tubal ligation and ovarian cancer risk in a large cohort: Substantial variation by histological type.
    Int J Cancer. 2015 Sep 17. doi: 10.1002/ijc.29856.
    PubMed     Text format     Abstract available


  36. HUANG T, Eliassen AH, Hankinson SE, Okereke OI, et al
    A prospective study of leisure-time physical activity and risk of incident epithelial ovarian cancer: Impact by menopausal status.
    Int J Cancer. 2015 Sep 3. doi: 10.1002/ijc.29834.
    PubMed     Text format     Abstract available



  37. Erratum-ovarian cancer cells, not normal cells, are damaged by mirk/dyrk1b kinase inhibition.
    Int J Cancer. 2015;137:E13.
    PubMed     Text format    


    August 2015
  38. GANAPATHI MK, Jones WD, Sehouli J, Michener CM, et al
    Expression profile of COL2A1 and the pseudogene SLC6A10P predicts tumor recurrence in high grade serous ovarian cancer.
    Int J Cancer. 2015 Aug 27. doi: 10.1002/ijc.29815.
    PubMed     Text format     Abstract available


  39. PERMUTH-WEY J, Fulp WJ, Reid BM, Chen Z, et al
    STAT3 Polymorphisms May Predict an Unfavorable Response to First-Line Platinum-based Therapy for Women with Advanced Serous Epithelial Ovarian Cancer.
    Int J Cancer. 2015 Aug 11. doi: 10.1002/ijc.29799.
    PubMed     Text format     Abstract available


    July 2015
  40. HAFNER N, Steinbach D, Jansen L, Diebolder H, et al
    RUNX3 and CAMK2N1 hypermethylation as prognostic marker for epithelial ovarian cancer.
    Int J Cancer. 2015 Jul 15. doi: 10.1002/ijc.29690.
    PubMed     Text format     Abstract available


  41. DENT BM, Ogle LF, O'Donnell RL, Hayes N, et al
    High-resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers.
    Int J Cancer. 2015 Jul 14. doi: 10.1002/ijc.29680.
    PubMed     Text format     Abstract available


    June 2015
  42. COCCO E, Shapiro EM, Gasparrini S, Lopez S, et al
    Clostridium Perfringens Enterotoxin C-terminal domain labeled to fluorescent Dyes for in vivo visualization of micro-metastatic chemotherapy-resistant ovarian cancer.
    Int J Cancer. 2015 Jun 9. doi: 10.1002/ijc.29632.
    PubMed     Text format     Abstract available


    April 2015
  43. GOUNDIAM O, Gestraud P, Popova T, De la Motte Rouge T, et al
    Histo-genomic stratification reveals the frequent amplification/overexpression of CCNE1 and BRD4 genes in non-BRCAness high grade ovarian carcinoma.
    Int J Cancer. 2015 Apr 17. doi: 10.1002/ijc.29568.
    PubMed     Text format     Abstract available


    March 2015
  44. FARKKILA A, Koskela S, Bryk S, Alfthan H, et al
    The clinical utility of serum Anti-Mullerian hormone in the follow-up of ovarian adult-type granulosa cell tumors - a comparative study with inhibin B.
    Int J Cancer. 2015 Mar 24. doi: 10.1002/ijc.29532.
    PubMed     Text format     Abstract available


    October 2014
  45. LEE EK, Song KA, Chae JH, Kim KM, et al
    GAGE12 mediates human gastric carcinoma growth and metastasis.
    Int J Cancer. 2014 Oct 23. doi: 10.1002/ijc.29286.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: